Ann: Bit225 Covid-19 Human Study Commenced, page-99

First 99 Last

Share
Profile

Follow
Michael Yoni

148 Posts.

12

15/09/22

10:52

Post #: 63712342
Share

Originally posted by nailsnglue: ↑

Antibody response in HIV-infected individuals tends to have half the antibody response to vaccines compared with other groups. The only other group which is is lower is organ transplant recipients who are on a range of anti-rejection drugs. You don't need to find all the same people for a study, just get a baseline and then daily antibodies and symptom score sheet. Those that are vaccinated will have perhaps higher IGg to start with but around 30% of HIV infected (vs 5% general population) individuals lose their IGg within 3 months of infection or vaccination. source. I still feel that with around .5 of the average population likely to contract or be exposed to COVID19 during six months we shall see some interesting data. It is said that immuno-compromised people have three times more chance of contracting severe COVID19 symptoms when exposed. So it is likely we do see some interesting data. This is all irrespective of ART-naive or not and is probably more related to individual CD4 levels. It will be difficult to put this into context in the study but not impossible.

We have a small study, yes, but we have no money and yet to spike interest from big money. This is a favourable step in the direction we want to take.

Expand

With respect to the immunocompromised .... in the article did they specifically say they are HIV pos or are they other immunocompromised conditions. They do have a * on the table....

BIT Price at posting: 5.7¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

QHL

Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer

PFE

Pantera begins drilling of maiden test well at Smackover

C29

C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 90 more messages in this thread...

First 99 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change 0.001(5.26%)		Mkt cap ! $18.04M

Open	High	Low	Value	Volume
2.0¢	2.1¢	2.0¢	$9.288K	460.4K

Buyers (Bids)

No.	Vol.	Price($)
1	15038	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	24000	1

View Market Depth

No.	Vol.	Price($)
1	15038	0.020
4	1410807	0.019
12	2330053	0.018
6	718000	0.017
12	1556225	0.016

Price($)	Vol.	No.
0.021	24000	1
0.022	440000	2
0.023	307000	2
0.024	100035	2
0.025	620000	4

Last trade - 15.05pm 07/11/2024 (20 minute delay)

BIT (ASX) Chart

Ann: Bit225 Covid-19 Human Study Commenced, page-99

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer

Pantera begins drilling of maiden test well at Smackover

C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Bit225 Covid-19 Human Study Commenced, page-99

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer

Pantera begins drilling of maiden test well at Smackover

C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News